Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/067,326external-prioritypatent/US4797413A/en
Application filed by Merck & Co. Inc.filedCriticalMerck & Co. Inc.
Publication of BG96092ApublicationCriticalpatent/BG96092A/en
Publication of BG60887B1publicationCriticalpatent/BG60887B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
Съединенията са карбонатанхидразни инхибитори и могат да се използват в хуманната медицина за лечение на повишено вътреочно налягане, по-специално при глаукома. При лечението на повишено очно налягане те се използват в комбинация с офталмологично поносим носител.The compounds are carbonate hydrazine inhibitors and can be used in human medicine to treat elevated intraocular pressure, particularly in glaucoma. In the treatment of elevated ocular pressure, they are used in combination with an ophthalmologically tolerable carrier.
BG96092A1987-06-261992-03-18Thienethiopyran sulphonamide derivatives and their application in ophthalmological preparations
BG60887B1
(en)
Use of 1-(p-isopropoxyethoxymethyl-phenoxy)-3-isopropylaminopropan-2-ol for the preparation of a medicament for the reduction of internal pressure in the eye